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Abstract: The review highlights the main results of two decades of research on climacostol
(5-[(2Z)-non-2-en-1-yl]benzene-1,3-diol), the resorcinolic lipid produced and used by the ciliated
protozoan Climacostomum virens for chemical defense against a wide range of predators, and to
assist its carnivorous feeding. After the first studies on the physiological function of climacostol,
the compound and some analogues were chemically synthesized, thus allowing us to explore both its
effect on different prokaryotic and eukaryotic biological systems, and the role of its relevant structural
traits. In particular, the results obtained in the last 10 years indicate climacostol is an effective
antimicrobial and anticancer agent, bringing new clues to the attempt to design and synthesize
additional novel analogues that can increase or optimize its pharmacological properties.
Keywords: Climacostomum virens; secondary metabolites; predator–prey interactions; resorcinolic
lipids; ciliates; natural products
1. Introduction
Aquatic organisms live in environments which are exceptionally full of competitive biodiversity
and for this reason have evolved a great number of adaptive strategies to survive and reproduce,
which in eukaryotic unicellular microbes (protists) appear particularly well represented. At the
molecular level, ciliated protists show adaptive strategies based on at least two classes of compounds,
pheromones and secondary metabolites. Pheromones are diffusible proteins produced and secreted
by different ciliate species to mediate self–nonself recognition mechanisms, responsible for cell shift
between the vegetative and sexual stages of the cell biological cycle (see [1] for a review). Secondary
metabolites produced by ciliates include toxic substances either stored in the cell cytoplasm or inside
ejectable organelles (known as extrusomes) that are anchored to the cell cortex before being used in
predator-prey and cell-environment interactions [2,3]. These secondary metabolites are synthesized
through different biogenetic routes and have been named from the taxonomic names of their source
organisms. Some metabolites are biosynthesized via the polyketide pathway (or mixed biogenetic
routes), whilst several others derive from the classical terpenoid biogenesis (see [3,4] for a review).
Representative examples are the terpenoid euplotins from Euplotes species [5] and some polycyclic
aromatic compounds built on hypericin structure such as blepharismins from Blepharisma species [6,7],
stentorins from Stentor coeruleus [8], amethystin from Stentor amethystinus [9], and maristentorin from
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Maristentor dinoferus [10]. Other toxic secondary metabolites are spirostomin from Spirostomum teres [11]
and mono-prenyl hydroquinone from Spirostomum ambiguum [12]. Keronopsins, keronopsamides and
erythrolactones are, instead, produced by three different species of the genus Pseudokeronopsis: P. rubra,
P. riccii and P. erythrina [7,13–16], respectively (Figure 1).
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Figure 1. Relevant secondary met s ith biological activities produced by ciliated protists.
Blepharismins: BP-A (R1 C2H5; R2 = C2H5; R3 = H); BP-B ( 1 = 2H5; R2 = i-C3H5; R3 = H);
BP-C (R1 = R2 = i-C3H5; R3 = H); BP-D (R1 = C2H5; R2 = i-C3H5; R3 = C 3); BP-E (R1 = R2 = i-C3H5;
R3 = CH3). Stentorins: S-C (R1 = i-C3H5; R2 = i-C3H5; R3 = H). Erythrolactones: E-1 (R1 =SO3;
R2 = C6H13); E-2 (R1 =SO3; R2 = C7H15); E-3 (R1 =SO3; R2 = C8H17); E-4 (R1 =H; R2 = C6H13);
E-5 (R1 =H; R2 = C7H15); E-6 (R1 =H; R2 = C8H17). Redrafted from [3] and reproduced under the
Creative Commons attribution 3.0 license: https://creativecommons.org/licenses/by/3.0/.
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Climacostol (5-[(2Z)-non-2-en-1-yl]benzene-1,3-diol) is a toxic secondary metabolite physiologically
produced by the freshwater ciliate Climacostomum virens (Figure 2) for chemical defense against
unicellular and multicellular predators, or for chemical offence to assist its carnivorous feeding [3,17].
This molecule is formed by a phenolic skeleton and a long unsaturated aliphatic hydrocarbon chain
attached to the ring structure, and belongs to resorcinolic lipids (or alkenylresorcinols), a group of
natural amphiphilic compounds detected in both prokaryotes and eukaryotes. The 5-alkenylresorcinols
usually have an isolated double bond in the chain portion of the molecule, while examples with a
conjugated double bond with aromatic ring are unusual [18]. A possible pathway for the biosynthesis
of climacostol was proposed from the C16-polyketide, with a cyclization and a decarboxylation [19],
and the toxin was also obtained by chemical synthesis [19,20]. More recently, climacostol has been
synthetized as a pure compound in the natural and most bioactive Z-configuration by a novel and
straightforward synthesis [21], which has allowed researchers to better study its effects on different
biological systems.
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2. Climacostol Mediates Predator–Prey Interactions
Climacostomum virens is a noncontractile freshwater heterotrich ciliate, which often looks green
due to the presence of endosymbiotic algae (Chlorella sp.). The green cells can be cultivated in the
dark to reduce or eliminate the symbionts, in order to obtain colorless strains [17,22]. C. virens possess
numerous extrusomes reported as cortical granules (or granulocysts) which are able to discharge their
content to the outside of the cell in response to external stimuli. The colorless extruded substances are
mainly represented by climacostol with the presence of some related analogues [16,18]. The defensive
function of climacostol was first demonstrated against the raptorial ciliate Dileptus margaritifer. Indeed,
when this predator touches a cell of C. virens with its toxicyst-bearing proboscis, D. margaritifer swims
backward and a condensed substance, raised from the site of contact, becomes visible under a dark-field
microscope. After other attacks by the same individual, the proboscis of D. margaritifer appears shorter
and visibly damaged, whereas subsequent attacks can lead to the death of the predator due to the
cytotoxic effect of climacostol [17]. More recently, the toxic action of climacostol against metazoan
predators was also demonstrated [23], and it was furthermore assumed that C. virens is able to use
climacostol for chemical offense, to paralyze and kill prey [3].
3. Climacostol Exerts Cytotoxic and Antimicrobial Effect
Initially, the cytotoxic effect of climacostol was analyzed against a panel of nine free-living ciliate
species which share the same microhabitat with C. virens: Blepharisma japonicum, Didinium nasutum,
Dileptus margaritifer, Euplotes aediculatus, Paramecium tetraurelia, Spirostomum ambiguum,
Spirostomum teres, Stentor coeruleus, and Stentor niger. It was demonstrated that the cytotoxic potency of
climacostol is related to the molecular structure of the unsaturated side chain, and that it could be
modulated by the substitution of the double bond with a single or a triple one at the C8 position [24].
In fact, while the saturated alkyl derivative showed the highest cytotoxicity against the tested species,
the alkynyl derivative that carries a triple bond in the side chain showed the lowest cytotoxic potency.
An intermediate cytotoxicity was revealed by the native climacostol (with a double bond in the side
chain) (Figure 3).
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Figure 3. Cytotoxic effect of climacostol and its alkyl and alkynyl derivatives on ten ciliate species.
Cell viability was assessed after 24 h, and each bar represents the mean (±SE) of 3 independent
experiments. * p < 0.05 and ** p < 0.001. Original data from [24].
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In a further study, the effect of climacostol and its alkyl and alkynyl derivatives was
also tested on some Gram-positive and Gram-negative pathogen bacteria and on the fungus
Candida albicans [25]. The results showed an appreciable and comparable antimicrobial activity
of the three compounds, which were effective against Gram-positive bacteria and C. albicans with
Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentration (MBC) ranging
from 8 to 32 mg L−1. By contrast, no significant toxicity against Gram-negative species (Escherichia coli
and Pseudomonas aeruginosa) has been observed [25]. The authors speculated that this limited effect
observed on the Gram-negative species can be explained by the peculiar structure of the bacterial cell
wall. The outer membrane is indeed a selective barrier to the penetration of several compounds, due to
the hydrophilic nature of the surface exposed to the environment and to the selectivity of the outer
membrane proteins. To summarize, the overall results suggest that the saturation rate of the side chain
of climacostol does not couple to its antimicrobial activity, whereas it is closely related to the cytotoxic
action against ciliated protists. Therefore, it is likely that the general structure of the two moieties of
climacostol, i.e., the di-hydroxy-phenyl group and the alkenyl chains, contributes to the antibiotic
action as a whole. In general, the presence of a double bond in the hydrocarbon chain is associated
with an increase in cell viability as compared to the saturated compounds, and an increase in the chain
length does not interfere with the effect of aromatic ring substituents, which is clearly predominant [26].
4. Climacostol Reduces Tumor Progression via p53-Dependent Apoptosis
On the basis of anticancer activity displayed by a number of other resorcinolic lipids (see [27] for
a review), the effects of climacostol were initially explored in vitro on some human and rodent tumor
cell lines [28]. In particular, experiments performed on human tumor squamous carcinoma A431 cells,
and human promyelocytic leukemia HL60 cells demonstrated that climacostol exerts its action by
inhibiting cell growth and triggering a mitochondrion-dependent apoptotic program. Subsequent
extensive in vitro screenings and in vivo experiments confirmed the previous observations [4,21,29–31].
Although climacostol cytotoxicity appears more selective against tumors than certain immortalized
nontumor cells [21,29], recent data suggest that climacostol effects are not necessarily correlated to the
cancerous origin of cells [31]. However, the possibility that climacostol preferentially affects cancerous
vs. normal (nontransformed non-immortalized) cells requires further investigation.
With regard to the action mechanism of climacostol, it was demonstrated that the protozoan toxin
can trigger apoptosis by binding to nuclear and mitochondrial DNA, and promoting their cleavage after
the generation of reactive oxygen species (ROS) in the presence of Cu(II) [32,33]. It is known that the
induction of DNA damage could be effective in treating cancer, and many currently employed antitumor
drugs, for example, platinum agents, function by means of this mechanism [34–36]. In this role, it was
shown that cisplatin and climacostol do not display any additive effects on melanoma viability [29].
Recent investigations on the mechanisms of action of climacostol demonstrated that it reduces the
viability/proliferation of melanoma cells, causing rapidly occurring DNA damage, also inducing the
intrinsic apoptotic pathway characterized by the dissipation of the mitochondrial membrane potential,
the translocation of Bax to the mitochondria, the release of cytochrome c from the mitochondria, and the
activation of caspase 9-dependent cleavage of caspase 3 [29,30]. Additionally, persistent inhibition of
the growth of melanoma allografts as well as a reduction in the number of viable and proliferating
tumor cells was achieved after intratumoral injections of the toxin [4,29]. The notion that climacostol
may induce a decrease in the microvessel sprouting that contributes to inhibition of melanoma growth
was also suggested [4]. As shown in Figure 4, a significant improvement in survival of transplanted
mice was reported, together with a decrease of tumor weight, and a reduction of viable cells inside the
tumor. Of interest, the signaling events responsible for the climacostol-induced pro-apoptotic effects
rely on the upregulation of the p53 network and its targets Noxa and Puma [4].
Microorganisms 2020, 8, 809 6 of 13
Microorganisms 2020, 8, x FOR PEER REVIEW 2 of 15 
 
 
Figure 4. In vivo antitumor properties of climacostol in mice bearing melanoma allografts. When the 
B16-F10 syngeneic implantation was established, animals were intratumor injected with vehicle 
(control) or climacostol at 600 μg/mL every 3–4 days for 3 weeks. (A) Typical photographs taken at 
different time points and depicting the growth of subcutaneous melanomas, as indicated by red 
circles. (B) Tumor growth monitored by means of external caliper measurements and volume 
calculation. Arrows indicate the day of climacostol treatment. (C) Percentage survival analyzed by 
Kaplan–Meier curve. Images and data points in (A–C) represent the results obtained from 7–15 
animals per experimental group. (D) Typical photographs of subcutaneous melanoma allografts 
excised from mice at day 16 of treatment (on day 0 and then every 3–4 days) with vehicle (control) or 
climacostol (600 μg/mL). Scale bar: 5 mm. (E) Weight of the excised tumors. Images and data in (D, 
E) represent the results obtained from 3 animals per experimental group. *p < 0.001 vs the respective 
control. Original picture from [29] and reproduced under the Creative Commons attribution 4.0 
license: http://creativecommons.org/licenses/by/4.0/. 
Figure 4. In vivo antitumor properties of climacostol in mice bearing melanoma allografts. When the
B16-F10 syngeneic implantation was established, animals were intratumor injected with vehicle
(control) or climacostol at 600 µg/mL every 3–4 days for 3 weeks. (A) Typical photographs taken
at different time points and depicting the growth of subcutaneous melanomas, as indicated by
red circles. (B) Tumor growth monitored by means of external caliper measurements and volume
calculation. Arrows indicate the day of climacostol treatment. (C) Percentage survival analyzed by
Kaplan–Meier curve. Images and data points in (A–C) represent the results obtained from 7–15 animals
per experimental group. (D) Typical photographs of subcutaneous melanoma allografts excised from
mice at day 16 of treatment (on day 0 and then every 3–4 days) with vehicle (control) or climacostol
(600 µg/mL). Scale bar: 5 mm. (E) Weight of the excised tumors. Images and data in (D,E) represent
the results obtained from 3 animals per experimental group. * p < 0.001 vs the respective control.
Original picture from [29] and reproduced under the Creative Commons attribution 4.0 license:
http://creativecommons.org/licenses/by/4.0/.
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5. Climacostol Induces Dysfunctional Autophagy in Tumor Cells
In all the eukaryotic cells, a pivotal role for the maintenance of homeostasis is played by autophagy,
the highly conserved process which operates via the degradation of cytoplasmic organelles, proteins,
and macromolecules, and the recycling of the breakdown products. As autophagy supports cell
survival or activates death pathways, it may represent a potential target for the available library of
anticancer substances and for the development of new molecules.
Some of us recently reported on how climacostol regulates autophagy and the involvement
of p53-dependent mechanisms [30]. Essentially, our data indicated that the protozoan toxin
potently and selectively impairs autophagy in multiple tumor cells that are committed to dying
by apoptosis. Climacostol exerts a marked and sustained accumulation of autophagosomes as the
result of dysfunctional autophagic degradation. Mechanistic insights showed that climacostol affects
autophagosome turnover via p53-AMPK axis, although the mTOR pathway unrelated to p53 levels
plays a role. Of note are indications suggesting that climacostol effects on autophagy and apoptosis are
actually two separate events, which may act independently on life/death decisions of the cell.
In this picture, the upregulation of the p53 system appears at the molecular crossroads regulating
both the anti-autophagic action of climacostol and its role in the induction of apoptosis.
6. The Synthetic Analogues of Climacostol for Biotechnological Applications
The results collected in the last 20 years regarding the activity of climacostol together with the
structural properties of other resorcinolic lipids allowed us to design and obtain new synthetic analogues
of the protozoan toxin. These compounds shed light on the chemical bases of climacostol actions.
Two analogues, methyl-5 [(2Z)-non-2-en-1-yl]benzene-1,3-diol (AN1) and 5-[(2Z)-non-2-en-
1-yl]benzene-1,2,3-triol (AN2), respectively carrying an additional methyl group and a hydroxyl
group in the aromatic ring, were analyzed for their biological activity [31] (Figure 5).
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The choice to introduce the aforementioned moieties into the aromatic ring of climacostol was
supported by the observation that similar modification perfor ed on some polyphenols and phenolic
lipids resulted in a significant improvement of their cytotoxic and antimicrobial activity [37,38].
The effects of AN1 and AN2 were investigated on mammalian cells, pathogenic microbes and
free-living ciliated protists, with the main purpose being to identify the structural traits of native
climacostol primarily involved in its cytotoxic activities.
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6.1. Antitumour Activity
The pro-apoptotic features of AN1 and AN2 on immortalized cell lines of both tumor (B16-F10,
GL261, SK-N-BE, and CT26) and nontumor (C2C12) origin were analyzed and compared with that of
climacostol. The results indicated that cell viability was negatively affected by the two analogues with
a comparable strength (Table 1), and both AN1 and AN2 displayed similar or even lower potencies
when compared to climacostol [31]. Furthermore, as in the case of various tumor cells exposed to
climacostol [4,29,30], immunostaining techniques revealed that B16-F10 melanoma cells expressed high
levels of active caspase 3 after AN1 and AN2 treatment (Figure 6), thus demonstrating the activation of
an apoptotic pathway induced by both analogues.
Table 1. Induction of inhibition of cell viability by means of climacostol and its analogues. EC50 (µg/mL)
= the concentration producing half of the maximum effect. Original data from [31].
Cell lines Origin EC50
Climacostol AN1 AN2
B16-F10 mouse melanoma 12.81 18.88 37.94 *
GL261 mouse glioma 28.87 27.32 21.79
SK-NE-BE human neuroblastoma 19.13 34.31 * 39.84 *
CT26 mouse colon cancer 31.58 36.11 27.42
C2C12 myoblast of mouse 16.19 29.28 * 31.72 *
* p < 0.0001 from climacostol value (F-test); n = 3.
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6.2. Antimicrobial Activity
AN1 and AN2 were also investigated with dose–response experiments performed to compare
their cytotoxic potential against a panel of microorganisms comprising bacterial and fungal pathogens,
and freshwater ciliates.
The data collected confirmed that both AN1 and AN2 show an appreciable cytotoxicity on all
the microorganisms exposed to different concentrations of the two analogues, with the exception
of Escherichia coli and Pseudomonas aeruginosa that proved to be immune to the toxins. AN1 was
the most toxic compound against pathogens and ciliates, whereas AN2 effects were comparable
to or worse than climacostol. In particular, AN1 showed MIC and MBC values of 8 µg/mL
against the Gram-positive Staphylococcus aureus and Enterococcus faecalis, respectively, and a value
of 4 µg/mL against the fungus Candida albicans. In experiments with ciliates, the highest toxicity of
AN1 (0.64 µg/mL < LC50 < 2.15 µg/mL) was observed against B. japonicum, P. multimicronucleatum,
S. ambiguum, and S. teres [31].
With regard to the action mechanism of the synthetic toxins, the cytotoxicity of both AN1 and
AN2 on some ciliate species appeared to be mediated by a necrotic process, as previously reported
for the effect of climacostol on free-living ciliates [17,24]. An exception was represented by the ciliate
Euplotes aediculatus which displayed the activation of programmed cell death triggered by AN2.
In fact, Terminal deoxyribonucleotidyl transferse (TdT)-mediated biotin-16-dUTP Nick-End Labelling
(TUNEL) fluorescence assay and light microscopy observations on Euplotes specimens exposed to AN2
revealed the typical sequence of events associated with canonical apoptosis, such as the progressive
fragmentation of the macronucleus during the early stages in the absence of major changes in cell
morphology, and the lack of severe necrotic damage, such as cell swelling and rupture [31] (Figure 7).
To summarize, whereas similar effects were substantially observed for climacostol and its analogues
on mammalian cells, AN1 was the most active compound against bacterial and fungal pathogens,
and protists. The hydroxyl group added to climacostol to obtain AN2 appears to be the pivotal structural
trait transforming the protozoan toxin into an apoptosis-inducing compound in unicellular eukaryotes.
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The overall results obtained with AN1 and AN2 encourage the attempt to design and synthetize
additional novel analogues of climacostol that can increase or optimize its pharmacological properties.
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7. Climacostol as a Prodrug
During the synthesis of climacostol, the choice of the methoxymethyl ether (MOM) protecting
group, which can be removed in a weakly acidic environment, allowed the researchers to efficiently
obtain the toxin in the biologically active (Z)-configuration climacostol [21] (Figure 8).
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This procedure was also applied to design a prodrug strategy based on pH activation, potentially
useful to deliver climacostol to acidic pathological multicellular (tumors) or unicellular (parasitophorous
of Leishmania and digestive vacuole of Plasmodium) targets [39]. In fact, the MOM-protected climacostol,
which the authors called MOMO, progressively shifts to active climacostol if exposed to pH values
lower than 7. This shifting was initially verified in a native biological system (against ciliates other than
C. virens) where ciliates exposed to MOMO in a physiological culture medium (SMB) at pH = 6.8 did
not reveal any sign of toxicity. On the contrary, MOMO resuspended in SMB at pH = 6.3 (not harmful
itself for ciliates) induced the same necrotic effect as climacostol [39].
In addition, it was demonstrated that the activity of MOMO could be modulated in a
dose-dependent manner to induce cytotoxic or cytostatic effects. The biological activity of MOMO
on some tumor cell lines confirmed that this molecule proved toxic in acidic conditions (pH < 6.8),
by yielding active climacostol. In these conditions, MOMO induces apoptosis in melanoma cells
confirming that it behaves with the same action mechanism as climacostol (Figure 9).
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Drosophila flies fed directly with acidic nutrients containing increasing concentrations of MOMO
showed a significant reduction in oviposition and survival of larvae, which also exhibited apoptotic
cells in the gut, as revealed by TUNEL labeling and cleaved-caspase 3 immunostaining. In addition,
mitosis was also reduced in brain tissue of larvae, thus suggesting that active MOMO exhibited
prolonged toxic effects after oral intake and gut absorption.
Overall, our data revealed that MOMO efficiently targets different tissues of the developing fly
with high metabolic/proliferating activity, such as midgut and brain.
8. Conclusions
Natural products possess enormous structural and chemical diversity that is unsurpassed by
any synthetic libraries. Notably, small organic molecules from nature have shown great translational
potential [40] since living organisms have a marked ability to synthetize complex molecular structures
with defined biological properties, and climacostol is a typical example as a small molecule. However,
the possibility to directly purify climacostol as a natural compound from cell cultures is actually limited
to very small amounts. Therefore, to address this problem, many efforts have been directed towards
the preparation of large amounts of synthetic climacostol and some analogues, through strategies
capable of making a cheaper and faster product.
The studies carried out in recent years on climacostol and its analogues have shown how the
alkenylresorcinol structure can exert both appreciable antimicrobial and antitumor activities. The resorcinol
moiety is in fact a widespread phenolic unit, which is found in several biologically active natural products [41],
as well as a synthetic derivative with biological activities that show considerable therapeutic potential.
Structure–activity relationship investigations in distinct alkenylresorcinols have shown that an increase
in the number of the ring substituents leads to higher cytotoxic activities in many cell lines compared
to climacostol. Therefore, it is interesting to note that an increase in the number of hydroxyl groups in
climacostol does not lead to an increase in antitumor activity, which can be comparable to or worse than that
of the native toxin. In this picture, further synthetic studies to better understand the relationship between
the biological activity of climacostol and the position of the substituents in its aromatic ring are currently
under development. The biological results will be reported as soon as they are available.
In conclusion, it appears that small molecule derivatives exhibiting optimum potency/selectivity
may have a pivotal role to play in understanding the biochemical machinery underlying cell function/
dysfunction as well as in exploiting new therapeutic indications. In this respect, climacostol appears to
be a promising lead compound for chemical organic approaches and biotechnological investigations
which merit exploitation by drug pharmacology.
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